[Expand product categories]

Cancer Peptide Inhibitors

Cancer Peptide Inhibitors for Targeted Oncology Research and Drug Discovery

Cancer peptide inhibitors are research-grade bioactive peptides designed to selectively block key signaling pathways involved in tumor growth, metastasis, angiogenesis, and cancer cell survival. These peptides are widely used in oncology research and drug discovery to investigate molecular mechanisms and validate therapeutic targets. At Linkpeptide, we offer a comprehensive portfolio of cancer peptide inhibitors covering apoptosis regulation, angiogenesis inhibition, cell cycle control, and tumor microenvironment modulation. Our peptides enable precise targeting of oncogenic pathways, supporting both basic research and preclinical development.

Default Ranking Price By Date
KYL

KYL

Details
Add Inquiry
Motixafortide

Motixafortide

$495.00
Details
Add Inquiry
Nelipcpimut-S

Nelipcpimut-S

$228.00
Details
Add Inquiry
Paclitaxel trevatide

Paclitaxel trevatide

$1,985.00
Details
Add Inquiry
PDZ1 Domain inhibitor peptide

PDZ1 Domain inhibitor peptide

Details
Add Inquiry
PKC β pseudosubstrate

PKC β pseudosubstrate

Details
Add Inquiry
PKC ζ pseudosubstrate

PKC ζ pseudosubstrate

Details
Add Inquiry
PNC-27

PNC-27

Details
Add Inquiry
Rac1 Inhibitor F56, control peptide

Rac1 Inhibitor F56, control peptide

Details
Add Inquiry
Rac1 Inhibitor W56

Rac1 Inhibitor W56

Details
Add Inquiry
Valspodar

Valspodar

$488.00
Details
Add Inquiry

What Are Cancer Peptide Inhibitors?

Cancer peptide inhibitors are short synthetic peptides engineered to disrupt specific protein functions or signaling cascades that drive cancer progression. Unlike traditional small molecules, peptide inhibitors can effectively interfere with protein–protein interactions (PPIs), which are critical in many oncogenic pathways. Key characteristics include:
  • High specificity toward target proteins and pathways
  • Ability to modulate intracellular and extracellular signaling
  • Reduced off-target toxicity compared to small molecules
  • Flexible design for sequence optimization and modification
These properties make peptide inhibitors powerful tools for studying complex cancer biology and developing next-generation therapeutics.

Key Types of Cancer Peptide Inhibitors

Our cancer peptide inhibitor category is organized based on major oncogenic mechanisms :

Apoptosis Pathway Inhibitors

Target regulators of programmed cell death such as caspases and Bcl-2 family proteins, helping researchers study tumor survival and apoptosis resistance. Use cases:
  • Apoptosis signaling analysis
  • Anti-cancer drug screening
  • Mechanisms of tumor cell survival

Angiogenesis Inhibitors

Designed to inhibit tumor-induced blood vessel formation by targeting pathways such as VEGF signaling and endothelial activation. Use cases:
  • Tumor vascularization studies
  • Anti-angiogenic therapy research
  • Metastasis inhibition models

Cell Cycle Inhibitors

Peptides that interfere with cyclins, CDKs, and checkpoint regulators to halt uncontrolled cancer cell proliferation. Use cases:
  • Cell cycle arrest studies
  • Cancer proliferation assays
  • CDK-target validation

Signal Pathway Inhibitors

Target core oncogenic pathways including MAPK/ERK, PI3K/AKT, and JAK/STAT signaling cascades. Use cases:
  • Pathway-specific inhibition research
  • Drug resistance mechanism studies
  • Combination therapy development
Explore related: Signal Transduction Peptide Inhibitors

Tumor Microenvironment Modulators

Peptides that regulate interactions between tumor cells and their surrounding microenvironment, including immune cells and stromal components. Use cases:
  • Immuno-oncology research
  • Tumor–immune interaction studies
  • Microenvironment-targeted therapy development

Applications of Cancer Peptide Inhibitors

Cancer peptide inhibitors are essential tools in modern oncology research: Target Validation Enable precise inhibition of specific proteins to confirm their role in cancer progression. Drug Discovery Serve as lead compounds or reference molecules in the development of targeted anti-cancer therapies. Mechanistic Studies Help dissect signaling pathways involved in apoptosis, metastasis, angiogenesis, and tumor growth. Combination Therapy Research Used alongside small molecules, antibodies, or biologics to evaluate synergistic therapeutic effects.

Why Choose Linkpeptide Cancer Peptide Inhibitors

  • Extensive coverage of cancer-related targets and pathways
  • High purity peptides with strict HPLC and MS validation
  • Reliable batch-to-batch consistency for reproducible research
  • Flexible customization options for sequence and modifications
  • Fast turnaround for custom peptide synthesis projects

Custom Cancer Peptide Inhibitor Services

In addition to our catalog products, Linkpeptide provides tailored solutions to support your research:
  • Custom peptide design and optimization
  • Functional modifications (PEGylation, labeling, cyclization)
  • Peptide library synthesis
  • Scale-up production for preclinical studies

FAQ

What are cancer peptide inhibitors used for?

They are used to block specific cancer-related pathways, enabling researchers to study tumor biology and identify therapeutic targets.

How do peptide inhibitors target cancer pathways?

They bind selectively to proteins or disrupt protein–protein interactions involved in signaling pathways such as PI3K/AKT or MAPK.

Are peptide inhibitors better than small molecule inhibitors?

Peptide inhibitors offer higher specificity and are particularly effective for targeting complex interactions that small molecules cannot easily disrupt.

Can I order custom cancer peptide inhibitors?

Yes, Linkpeptide offers custom synthesis services including sequence design, modification, and scale-up production.
Add InquiryUp to 12 can be added
Start Inquiry Clear All

Get a Quote

Get a Quote

*
*
*

unit

Submitting....
Successfu！
Submission failed! Please try again later.
Email error!
Phone error!

No products in the cart.